Ann: Target's Statement, page-6

This is my reading of the situation Tangey.

(1) I don't see the EMR share price retreating significantly with this offer on the table.
(2) I don't see any cash leaving EMR coffers to complete the transaction.
(3) Expensive litigation proceedings presumably dissipate.
(4) What is the value of remaining Bullzeye shares that would appear very difficult to sell and facing massive dilution through capital raisings?, or, alternatively get their hands in their pockets to stave off dilution?, and still have a holding that is difficult to unload.
(5) An opportunity for Bullseye SH'ers exists to realize fair value for their investment and either hold their new EMR shares or head for the exit and cash in on the way out.
(6) Completion of the offer and subsequent compulsory acquisition clears the way for EMR "to get on with it" and "potentially" realize even more value for all concerned.